4/A
Changes in Ownership
Trevi Therapeutics, Inc. Filed Acc 0001209191-22-040268
Options or other derivatives
- President & CEO acquired 275,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| GOOD JENNIFER L President & CEO | 2022-02-14 | Grant or award · Stock Option (right to buy) | +275,000 | 275,000 | D: show line 1 in the form |
Loading xslF345X03/doc4a.xml…